- Home
- KOPN vs TIL Comparison
KOPN vs TIL Comparison
Compare KOPN & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOPN
- TIL
- Stock Information
- Founded
- KOPN 1984
- TIL 2018
- Country
- KOPN United States
- TIL United States
- Employees
- KOPN N/A
- TIL N/A
- Industry
- KOPN Semiconductors
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- KOPN Technology
- TIL Health Care
- Exchange
- KOPN Nasdaq
- TIL Nasdaq
- Market Cap
- KOPN 85.7M
- TIL 134.5M
- IPO Year
- KOPN 1992
- TIL 2021
- Fundamental
- Price
- KOPN $1.29
- TIL $20.80
- Analyst Decision
- KOPN Strong Buy
- TIL Buy
- Analyst Count
- KOPN 3
- TIL 4
- Target Price
- KOPN $2.67
- TIL $100.33
- AVG Volume (30 Days)
- KOPN 1.7M
- TIL 110.1K
- Earning Date
- KOPN 11-12-2024
- TIL 11-13-2024
- Dividend Yield
- KOPN N/A
- TIL N/A
- EPS Growth
- KOPN N/A
- TIL N/A
- EPS
- KOPN N/A
- TIL N/A
- Revenue
- KOPN $44,266,305.00
- TIL N/A
- Revenue This Year
- KOPN $22.10
- TIL N/A
- Revenue Next Year
- KOPN $14.34
- TIL $2.65
- P/E Ratio
- KOPN N/A
- TIL N/A
- Revenue Growth
- KOPN 0.60
- TIL N/A
- 52 Week Low
- KOPN $0.56
- TIL $6.88
- 52 Week High
- KOPN $2.82
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- KOPN 66.13
- TIL 36.46
- Support Level
- KOPN $1.03
- TIL $19.01
- Resistance Level
- KOPN $1.48
- TIL $22.69
- Average True Range (ATR)
- KOPN 0.12
- TIL 2.53
- MACD
- KOPN 0.01
- TIL -0.27
- Stochastic Oscillator
- KOPN 57.78
- TIL 10.72
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.